Menstrual discomfort is one of the most common experiences that the majority of people with menstrual cycles are likely to face. It can range from mil...
Lupin Announces Appointment of New Independent DirectorTuesday February 2, 2021 at 12:32 pm
Mumbai, India, February 2, 2021: Lupin Limited (Lupin), the global pharmaceutical company, announced the appointment of Mr. Mark D. McDade as an Independent Director effective January 28, 2021.
Mr. McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies.
Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, “We are delighted to welcome Mr. Mark D. McDade on Lupin’s board. We are confident that his diverse experience across large, mid and development-stage companies across Specialty & Biologics, will help advance our growth journey.”
Mr. McDade holds a B.A. in History from Dartmouth College and MBA from Harvard Business School.